Quest Diagnostics Incorporated (NYSE:DGX) has scheduled a conference call for 22nd October 2020 at 8:30 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.questdiagnostics.com
Earnings Expectation
Quest Diagnostics Incorporated medical laboratories diagnostic provider, is reporting third quarter earnings results on Thursday 22nd October 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 3.73 per share from $ 2725.35 million in revenue. For the full year, analysts predict revenues of $ 8740.76 million, while looking forward to income of $ 8.71 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 8,400.00 million ~ $ 8,800.00 million, where as bottomline are predicted in a range of $ 7.50 ~ $ 9.00 per share
Click Here For More Historical Outlooks Of Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
